When the FDA updated the 1992 Mammography Quality Standards Act to require patients be informed directly if they have dense breasts, the move may have opened a “Pandora’s box,” Elisa Port, MD, chief of breast surgery at New York City-based Mount Sinai Health System and director of the Dubin Breast Center at Mount Sinai, told Becker’s.
Read the full post on Becker's Hospital Review - Healthcare News
